The Effectiveness of Early Mobilization for Acute Ischemic Stroke Treated With Rt-PA or IA Thrombectomy
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03680469 |
|
Recruitment Status :
Recruiting
First Posted : September 21, 2018
Last Update Posted : December 16, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Acute Ischemic Stroke | Behavioral: standard early rehabilitation Behavioral: adding early out-of-bed mobilization | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 150 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | Stroke Center, Department of Physical Medicine and Rehabilitation, National Taiwan University Hospital |
| Actual Study Start Date : | October 5, 2018 |
| Estimated Primary Completion Date : | September 2023 |
| Estimated Study Completion Date : | September 2023 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: standard early rehabilitation
The standard early rehabilitation program after acute stroke is an intervention regularly utilized in the stroke center of National Taiwan University Hospital.
|
Behavioral: standard early rehabilitation
The standard early rehabilitation program is an intervention regularly utilized in the stroke center of National Taiwan University Hospital. Activities performed in the standard early rehabilitation program within 24-72 hours of onset include(1) bed exercises including the joint range of motion exercise, bridge exercise, the straight leg raising exercise, stretching exercises, and facilitation techniques, and (2) functional training in which the patients are instructed to engage in the repetitive and systematic practice of tasks, such as rolling or sitting supported on the bed. |
|
Experimental: adding early out-of-bed mobilization
The adding early out-of-bed mobilization treatment will be defined as the patients with acute ischemic stroke who receive out-of-bed mobilization treatment in addition to standard early rehabilitation care.
|
Behavioral: standard early rehabilitation
The standard early rehabilitation program is an intervention regularly utilized in the stroke center of National Taiwan University Hospital. Activities performed in the standard early rehabilitation program within 24-72 hours of onset include(1) bed exercises including the joint range of motion exercise, bridge exercise, the straight leg raising exercise, stretching exercises, and facilitation techniques, and (2) functional training in which the patients are instructed to engage in the repetitive and systematic practice of tasks, such as rolling or sitting supported on the bed. Behavioral: adding early out-of-bed mobilization Early mobilization treatment involving out-of-bed, task-specific activities including rolling and sitting up, sitting unsupported out of bed, and standing within 24-72 hours of onset and accounting for more than two thirds of the treatment time in early rehabilitation . |
- The total score-change of the Postural Assessment Scale for Stroke Patients (PASS) assessment for postural stability [ Time Frame: at baseline, at 2 weeks after stroke, at 4 weeks after stroke, and at follow-up 3 months after stroke ]The Postural Assessment Scale for Stroke Patients (PASS): The PASS contains 12 four-level items of varying difficulty for assessing a patient's ability to maintain or change a given lying, sitting, or standing posture. Its total score ranges from 0 to 36. Higher values represent a better outcome and all subscales are summed as a total score.
- The total score-change of the Functional Independence Measure (FIM) assessment for daily living function [ Time Frame: at baseline, at 2 weeks after stroke, at 4 weeks after stroke, and at follow-up 3 months after stroke ]The total FIM with total score ranges from 13 to 126, which was used to assess each patient's capacities in terms of activities of daily living, comprises 18 seven-level items and assesses dependence in self-care, sphincter management, transfer, locomotion, communication, social interaction, and cognition. The functional independence of patient's capacities in terms of activity of daily living. Higher values represent a better outcome and all subscales are summed as a total score.
- Achievement of the three motor milestones [ Time Frame: within 2 weeks after stroke and within 4 weeks after stroke ]the achievement of the three motor milestones (yes or no)
- Safety/Adverse event outcome [ Time Frame: up to 4 weeks after stroke ]Number of participants with serious adverse event
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 20 Years to 85 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- for experimental group: first ischemic stroke episode to receive either medical therapy (including intravenous thrombolysis using recombinant tissue-type plasminogen activator within 3 hours of onset) or endovascular therapy within 8 hours of onset (including intravenous thrombolysis following thrombectomy); for control group: first ischemic stroke episode to receive general medical therapy;
- completely activities of daily living independent before stroke;
- age above 20 years old;
- stroke with unilateral hemiparesis lesions confirmed using magnetic resonance imaging or computed tomography;
- no other peripheral or central nervous system dysfunction;
- no active inflammation or pathologic changes in the joints;
- no other active medical problems; and
- able to react to verbal commands, with systolic blood pressure between 120 and 160 mm Hg when resting, oxygen saturation >92% (with or without supplementation), and a heart rate below 130 beats per minute when resting with temperature <38.5 ℃
Exclusion Criteria:
- unstable vital sign;
- medical conditions unrelated to the cerebrovascular accident but which have affected walking performance;
- any other cognitive, emotional, or behavioral impairments resulting in insufficient comprehension, understanding, or collaboration;
- unable receive the informed consent form
- acute deterioration within 24 hours or symptomatic intracerebral hemorrhage defined by a parenchymal hemorrhage type 2 within 36 hours with an increase of 4 points or more in National Institute of Health Stroke Scale;
- acute hydrocephalus within 24 hours of onset
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03680469
| Contact: Hsiao-Ching Yen, MS | 886-2-23123456 ext 53034 | jassicayen@yahoo.com.tw |
| Taiwan | |
| National Taiwan University Hospital | Recruiting |
| Taipei, Taiwan, 100 | |
| Contact: Hsiao-Ching Yen 0922218732 jassicayen@yahoo.com.tw | |
| Principal Investigator: | Jiann-Shing Jeng, PhD | Stroke Center & Department of Neurology, National Taiwan University Hospital |
| Responsible Party: | National Taiwan University Hospital |
| ClinicalTrials.gov Identifier: | NCT03680469 |
| Other Study ID Numbers: |
201807045RINB |
| First Posted: | September 21, 2018 Key Record Dates |
| Last Update Posted: | December 16, 2020 |
| Last Verified: | August 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Ischemic Stroke Acute Early intervention Mobilization |
|
Stroke Ischemic Stroke Ischemia Cerebrovascular Disorders Brain Diseases |
Central Nervous System Diseases Nervous System Diseases Vascular Diseases Cardiovascular Diseases Pathologic Processes |

